The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122693903 12269390 3 F 20160202 20160727 20160414 20160801 EXP JP-JNJFOC-20160411485 JANSSEN 69.00 YR E M Y 0.00000 20160801 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122693903 12269390 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) U U 0 3 MG/KG LYOPHILIZED POWDER
122693903 12269390 2 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) U U 0 3 MG/KG LYOPHILIZED POWDER
122693903 12269390 3 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) U U 0 3 MG/KG LYOPHILIZED POWDER
122693903 12269390 4 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) U U 0 3 MG/KG LYOPHILIZED POWDER
122693903 12269390 5 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 35TH DOSE U U 103772 4 MG/KG LYOPHILIZED POWDER
122693903 12269390 6 SS RHEUMATREX METHOTREXATE SODIUM 1 Oral U 0 6 MG UNSPECIFIED /wk
122693903 12269390 7 C ISONIAZID. ISONIAZID 1 Oral 0 300 MG UNSPECIFIED QD
122693903 12269390 8 C BAKTAR SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 0 UNSPECIFIED
122693903 12269390 9 C PARIET RABEPRAZOLE SODIUM 1 Oral 0 10 MG UNSPECIFIED QD
122693903 12269390 10 C FOLIAMIN FOLIC ACID 1 Oral 0 5 MG/KG UNSPECIFIED /wk
122693903 12269390 11 C MAGMITT MAGNESIUM OXIDE 1 Oral 0 330 MG UNSPECIFIED TID
122693903 12269390 12 C BUP-4 PROPIVERINE 1 Oral 0 20 MG UNSPECIFIED BID
122693903 12269390 13 C CELECOX CELECOXIB 1 Oral 0 200 MG UNSPECIFIED BID
122693903 12269390 14 C REMINYL GALANTAMINE 1 Oral 0 8 MG UNSPECIFIED BID
122693903 12269390 15 C NICERGOLINE NICERGOLINE 1 Oral 0 5 MG UNSPECIFIED BID
122693903 12269390 16 C POSTERISAN LIDOCAINE 1 Topical 0 UNSPECIFIED
122693903 12269390 17 C LOXONIN LOXOPROFEN SODIUM 1 Topical 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122693903 12269390 1 Rheumatoid arthritis
122693903 12269390 2 Rheumatoid arthritis
122693903 12269390 3 Rheumatoid arthritis
122693903 12269390 4 Rheumatoid arthritis
122693903 12269390 5 Rheumatoid arthritis
122693903 12269390 6 Rheumatoid arthritis
122693903 12269390 7 Antibiotic prophylaxis
122693903 12269390 9 Peptic ulcer
122693903 12269390 10 Prophylaxis
122693903 12269390 11 Constipation
122693903 12269390 12 Benign prostatic hyperplasia
122693903 12269390 13 Rheumatoid arthritis
122693903 12269390 16 Haemorrhoids
122693903 12269390 17 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
122693903 12269390 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
122693903 12269390 Pneumocystis jirovecii pneumonia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122693903 12269390 1 20101105 0
122693903 12269390 2 20110527 0
122693903 12269390 3 20130802 0
122693903 12269390 4 20131220 0
122693903 12269390 5 20151211 0
122693903 12269390 6 2009 20160205 0
122693903 12269390 7 20101015 20110623 0
122693903 12269390 8 20150615 0